李 俊年

Medicine & Life Sciences

1. Tuberculosis 100%
2. Taiwan 99%
3. Particulate Matter 46%
4. Lung Neoplasms 37%
5. Myeloid-Derived Suppressor Cells 37%
6. Mycobacterium tuberculosis 36%
7. Pleural Effusion 33%
8. Lung 32%
9. stevioside 32%
10. Adenocarcinoma of Lung 31%
11. Chronic Obstructive Pulmonary Disease 27%
12. Protein-Tyrosine Kinases 27%
13. Vehicle Emissions 25%
14. Malignant Pleural Effusion 25%
15. Walk Test 23%
16. Multidrug-Resistant Tuberculosis 22%
17. Hemoptysis 21%
18. Mechanical Ventilators 21%
19. Teratoma 21%
20. Air Pollution 20%
21. Neurosurgery 20%
22. Oxygen 19%
23. Soot 18%
24. Confidence Intervals 17%
25. Platinum 17%
26. Drug Resistance 16%
27. ipratropium drug combination fenoterol 16%
28. Rifampin 16%
29. Asthma 15%
30. Pharmaceutical Preparations 15%
31. Erlotinib Hydrochloride 15%
32. Pneumopericardium 15%
33. Pressure 15%
34. Pleurisy 14%
35. Ventilator Weaning 14%
36. Patient Care 14%
37. Ventilation 14%
38. Walking 13%
39. Exercise 13%
40. Respiratory Insufficiency 13%
41. Therapeutics 13%
42. Ethambutol 13%
43. lipoteichoic acid 13%
44. Isoniazid 12%
45. Artificial Respiration 12%
46. Thorax 12%
47. Odds Ratio 12%
48. Directly Observed Therapy 12%
49. Lung Diseases 12%
50. Pemetrexed 12%